Q2 2026
Read transcript →BridgeBio Pharma, Inc. (BBIO) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$69.52
+2.01%
Mkt Cap $13.32B
Q1 2026
Read transcript →Q4 2025
Read transcript →Q3 2025
Read transcript →Q2 2025
Read transcript →Q1 2025
Read transcript →